A 2005 warning published by the Food and Drug Administration stated that patients taking the cholesterol drug Crestor may face an increased risk of kidney failure or other kidney problems. The agency reported that cases of kidney failure had been reported among patients taking Crestor, as well as those taking other statin drugs.
The FDA’s Crestor warning was based on a review of pre-approval trials for Crestor, which found that some patients taking the drug experienced proteins or small amounts of blood in the urine. These symptoms could be early signs of kidney problems.
In March 2010, the FDA told the manufacturer of Crestor to add a new warning to the drug’s label after a study found that the drug may increase the risk of diabetes. According to a study published in The Lancet, patients taking Crestor were 9% more likely to be diagnosed with type-2 diabetes than non-users.
Researchers have identified other side effects associated with the use of Crestor. According to other research published by The Lancet in 2009, patients taking the drug may face an increased risk of cardiomyopathy or other heart problems. Researchers found that patients taking Crestor or other statins showed lower levels of an enzyme that is essential for normal heart function. Statins including Crestor could lower the amount of this enzyme in the bloodstream, putting patients at an increased risk of heart problems including cardiomyopathy.
The FDA has stated that it will continue to study the link between Crestor and side effects such as diabetes and kidney failure. Despite the multiple warnings linking the drug to these and other conditions, the FDA has not announced any current plans to issue a Crestor recall.
If you or a loved one used Crestor and experienced kidney problems, diabetes or other side effects, you may qualify to file a lawsuit. For a free legal evaluation, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.